Delivery Order SPE2DB20D3103-SPE2DB22FM2Y8
- Not listed
- This federal contract award is for the delivery of Lisinopril 40 mg tablets, with a ceiling value of $4,562.92, awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Lisinopril 40 mg tablets in quantities of 1,000 to the U.S. government. The contract, valued at $3,503.44, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of December 8, 2023 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 90-count bottles of the 20 mg lisinopril tablet. The $2,220.25 firm fixed-price delivery order falls under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of 40 mg Lisinopril tablets. The contract has a ceiling value of $4,312.22 and runs through February 27, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,157.75 firm fixed-price delivery order is for 4,564,886,290 tablets of the drug Lisinopril 10 mg. The contract has a completion date of June 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $6,524.03 delivery order contract is for the supply of Lisinopril 20 mg tablets, a cardiovascular medication. The contract has a period of performance through January 20, 2022 and utilizes a firm fixed price pricing structure. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger $999,999,999...
- This federal contract award is for the delivery of Lisinopril-HCTZ 20-25 mg tablets in 90-count packages to the Defense Logistics Agency (DLA). The award, valued at $1,062.00, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a firm fixed price and an ultimate completion date of April 26, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the military and...
- The federal contract award is for the delivery of 1,000 units of the pharmaceutical product Lisinopril-HCTZ 10-12.5 mg tablets. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,323.53 and a period of performance through March 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is an...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 1,000 units of the prescription drug Lisinopril 10 mg tablets. The contract, valued at $6,856.47, has an ultimate completion date of April 26, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare...
- This federal contract award, valued at $1,243.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,701,371 units of Lisinopril 20 mg tablets, a cardiovascular medication, with an ultimate completion date of April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM2Y8Delivery Order
This federal contract award is for the delivery of Lisinopril 40 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for a firm fixed price of $2,423.08. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/13/22 |